- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
South Korean Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
1 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
A326030 | ₩97,600.00 | -5.7% | 8.0% | ₩7.7t | ₩120,800.00 | PE226.2x | E50.6% | n/a | ||
A009420 New | ₩36,200.00 | -10.6% | -2.2% | ₩1.9t | ₩53,333.33 | PS14.1x | E93.9% | n/a |
Page 1 of 1